|
For the Three Months
Ended March 31, | ||||||||
| 2023 | 2022 | |||||||
| Non-GAAP Net Loss: | ||||||||
| Net loss | $ | (18,343 | ) | $ | (19,995 | ) | ||
| Add (deduct): | ||||||||
| Depreciation and amortization(1) | 2,566 | 1,799 | ||||||
| Stock-based compensation(2) | 4,694 | 3,456 | ||||||
| Amortization of lease intangible | 333 | 333 | ||||||
| Amortization of deferred costs on convertible notes | 466 | 312 | ||||||
| Loss on marketable securities | — | 858 | ||||||
| Acquisition and other(3) | 30 | 639 | ||||||
| Loss on sale of property and equipment | 91 | — | ||||||
| Charitable contribution of common stock | 370 | — | ||||||
| Impairment of assets | 27 | — | ||||||
| Non-GAAP Net Loss | $ | (9,766 | ) | $ | (12,598 | ) | ||
| Weighted-average number of shares outstanding used to compute Non-GAAP Net Loss per share, basic and diluted | 47,699,561 | 46,789,585 | ||||||
| Non-GAAP EPS, basic and diluted | $ | (0.20 | ) | $ | (0.27 | ) | ||
Xometry Reports First Quarter 2023 Results
 |  | More MCAD News
|
|
RELATED NEWS
